HomeVTGN • NASDAQ
add
Vistagen Therapeutics Inc
Previous close
$4.83
Day range
$4.65 - $4.86
Year range
$1.62 - $24.71
Market cap
127.56M USD
Avg Volume
275.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 411.40K | 129.06% |
Operating expense | 8.30M | -16.60% |
Net income | -6.35M | 34.95% |
Net profit margin | -1.54K | 71.60% |
Earnings per share | -0.22 | 85.33% |
EBITDA | -7.85M | 19.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 126.56M | 405.48% |
Total assets | 131.07M | 341.18% |
Total liabilities | 7.78M | -13.85% |
Total equity | 123.28M | — |
Shares outstanding | 27.03M | — |
Price to book | 1.06 | — |
Return on assets | -22.75% | — |
Return on capital | -24.10% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.35M | 34.95% |
Cash from operations | -4.54M | 54.34% |
Cash from investing | -32.30K | -158.40% |
Cash from financing | 93.52M | 30,852.55% |
Net change in cash | 88.95M | 967.82% |
Free cash flow | -3.16M | 48.17% |
About
Founded
1998
Headquarters
Website
Employees
37